decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / FECAL_OCCULT_BLOOD_TEST
Subscribe or sign in to view the full article.
Article Overview
This page presents national coverage guidance for fecal occult blood testing (FOBT) and explains the general clinical contexts in which the test is discussed. It is useful for coders, billers, and compliance staff who need to understand the scope of Medicare coverage policy, the broad categories of indications and limitations addressed, and the relationship between FOBT and colorectal cancer screening claims.
Why This Topic Matters
FOBT appears in both diagnostic and screening settings, so coverage and billing context matter for correct claim reporting and policy compliance. This article helps users identify when the manual discusses testing for suspected bleeding-related conditions, when repeat testing frequency is limited, and when a separate screening-oriented HCPCS billing pathway is referenced.
Article Sections
-
Fecal Occult Blood Test
Introduces the coverage topic and provides general background on fecal occult blood testing and the forms of testing discussed in the manual.
-
Indications
Summarizes the broad clinical situations addressed by the policy for considering fecal occult blood testing.
-
Limitations
Outlines the general reporting and frequency limitations described in the coverage guidance, including a separate note related to screening context.
What You Will Learn
- What Medicare coverage guidance covers for fecal occult blood testing
- The broad clinical contexts discussed in the manual
- The general types of limitations and reporting considerations referenced by the policy
- How the article distinguishes diagnostic use from screening-related billing context
Who Should Read This
- Medical coders
- Billers
- Compliance staff
- Revenue cycle professionals
- Clinical documentation staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com